New AI-driven CSF liquid biopsy reads DNA methylation with M-PACT to identify brain tumors noninvasively. High accuracy, strong potential for pediatric care.
AI-Powered CSF Liquid Biopsy for Brain Tumors: M-PACT Breakthrough Read More »
Explore how AI can transform NHS patient access, strengthen cybersecurity, and power preventive health and workforce support across the UK health system.
AI in UK Healthcare: Solving Digital Access, Cyber Risk and Preventive Care Gaps Read More »
AI in drug discovery is set to grow 25-30% over five years. Read a concise briefing on drivers, key applications like oncology, major innovations and remaining hurdles.
AI in Drug Discovery: Trends, Partnerships and the Road Ahead Read More »
A concise expert digest on recent healthcare developments and practical AI applications across primary care, finance, integrated delivery, pharma and sustainable investments.
AI in Healthcare: Strategic Responses to Recent Sector Shifts Read More »
Agentic AI forms collaborative in silico teams that speed drug discovery, biomarker discovery and data analysis while raising validation and governance questions.
Agentic AI and In Silico Team Science: Accelerating Biomedical Research Read More »
How recent UK policy moves open the door for AI to improve primary care, screening, referral management, and personalised support while strengthening data governance.
AI in UK Healthcare: Turning Policy Shifts into Primary Care and System Gains Read More »
DeepRare, developed at Shenhua Hospital, raises rare disease diagnostic accuracy to 57% with clinical data and over 70% with genetics, offering traceable AI reasoning for clinicians worldwide.
How DeepRare Is Redefining Rare Disease Diagnosis in China and Beyond Read More »
A concise translation of a UTAUT study among doctors and nurses in North India: the practical drivers, barriers, and tactical steps hospital leaders and vendors can use to increase clinical AI uptake.
Why Doctors and Nurses Adopt Health AI: Lessons from a UTAUT Study in India Read More »
DeepRare, developed by Shanghai Jiao Tong University and Xinhua Hospital, uses an agentic AI workflow to shorten rare disease diagnosis — outperforming Exomiser in Recall@1.
Agentic AI DeepRare Accelerates Rare Disease Diagnosis with Human-like Reasoning Read More »
How AI is easing mental health demand, reducing surgical backlogs and improving supply chains. Practical examples, policy notes, and a forward-looking outlook.
AI Innovations Addressing Emerging Healthcare Challenges Read More »
